479 related articles for article (PubMed ID: 15681426)
21. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.
Beattie E; Denzler KL; Tartaglia J; Perkus ME; Paoletti E; Jacobs BL
J Virol; 1995 Jan; 69(1):499-505. PubMed ID: 7527085
[TBL] [Abstract][Full Text] [Related]
22. Replication of herpes simplex virus 1 depends on the gamma 134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection.
Jing X; Cerveny M; Yang K; He B
J Virol; 2004 Jul; 78(14):7653-66. PubMed ID: 15220440
[TBL] [Abstract][Full Text] [Related]
23. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors.
Terenzi F; deVeer MJ; Ying H; Restifo NP; Williams BR; Silverman RH
Nucleic Acids Res; 1999 Nov; 27(22):4369-75. PubMed ID: 10536144
[TBL] [Abstract][Full Text] [Related]
24. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.
Rivas C; Gil J; Mĕlková Z; Esteban M; Díaz-Guerra M
Virology; 1998 Apr; 243(2):406-14. PubMed ID: 9568039
[TBL] [Abstract][Full Text] [Related]
25. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.
Flodström-Tullberg M; Hultcrantz M; Stotland A; Maday A; Tsai D; Fine C; Williams B; Silverman R; Sarvetnick N
J Immunol; 2005 Feb; 174(3):1171-7. PubMed ID: 15661870
[TBL] [Abstract][Full Text] [Related]
26. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
Guidotti LG; Morris A; Mendez H; Koch R; Silverman RH; Williams BR; Chisari FV
J Virol; 2002 Mar; 76(6):2617-21. PubMed ID: 11861827
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey EE; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33811184
[TBL] [Abstract][Full Text] [Related]
28. Regulation of de novo translation of host cells by manipulation of PERK/PKR and GADD34-PP1 activity during Newcastle disease virus infection.
Liao Y; Gu F; Mao X; Niu Q; Wang H; Sun Y; Song C; Qiu X; Tan L; Ding C
J Gen Virol; 2016 Apr; 97(4):867-879. PubMed ID: 26869028
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of interferon action. Effect of double-stranded RNA and the 5'-O-monophosphate form of 2',5'-oligoadenylate on the inhibition of reovirus mRNA translation in vitro.
Miyamoto NG; Jacobs BL; Samuel CE
J Biol Chem; 1983 Dec; 258(24):15232-7. PubMed ID: 6197414
[TBL] [Abstract][Full Text] [Related]
30. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
Feng Z; Cerveny M; Yan Z; He B
J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211
[TBL] [Abstract][Full Text] [Related]
31. Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation.
Gainey MD; Dillon PJ; Clark KM; Manuse MJ; Parks GD
J Virol; 2008 Jan; 82(2):828-39. PubMed ID: 17977969
[TBL] [Abstract][Full Text] [Related]
32. Preferential translation of reovirus mRNA by a sigma3-dependent mechanism.
Schmechel S; Chute M; Skinner P; Anderson R; Schiff L
Virology; 1997 May; 232(1):62-73. PubMed ID: 9185589
[TBL] [Abstract][Full Text] [Related]
33. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.
Ventoso I; Berlanga JJ; Almendral JM
J Virol; 2010 May; 84(10):5043-51. PubMed ID: 20219905
[TBL] [Abstract][Full Text] [Related]
34. Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C.
Yu SH; Nagayama K; Enomoto N; Izumi N; Marumo F; Sato C
Hepatology; 2000 Nov; 32(5):1089-95. PubMed ID: 11050060
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.
Chinsangaram J; Koster M; Grubman MJ
J Virol; 2001 Jun; 75(12):5498-503. PubMed ID: 11356957
[TBL] [Abstract][Full Text] [Related]
36. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
37. Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection.
Cassady KA
J Virol; 2005 Jul; 79(14):8707-15. PubMed ID: 15994764
[TBL] [Abstract][Full Text] [Related]
38. Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus.
Child SJ; Jarrahian S; Harper VM; Geballe AP
J Virol; 2002 May; 76(10):4912-8. PubMed ID: 11967308
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.
Jha BK; Polyakova I; Kessler P; Dong B; Dickerman B; Sen GC; Silverman RH
J Biol Chem; 2011 Jul; 286(30):26319-26. PubMed ID: 21636578
[TBL] [Abstract][Full Text] [Related]
40. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
Li S; Min JY; Krug RM; Sen GC
Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]